Philippine News
Philippine News
Philippine News
More
By Neil Jerome Morales
MANILA (Reuters) - The Philippines continues to negotiate supply deals with a wide range
of COVID-19 vaccine makers, its health ministry said on Wednesday, despite its president
scolding Western firms and saying he wanted Chinese and Russian vaccines.
The Philippines, which has the most infections and second highest number of deaths in
Southeast Asia, is potentially a large market for vaccine makers with its population of 107
million.
"We are still continuously negotiating," Health Undersecretary Maria Rosario Vergeire told
Reuters in a text message. "No vaccine manufacturers have 'formally' asked for pre-
payment, though there have been insinuations during the discussions."
President Rodrigo Duterte on Monday lashed out at Western vaccine manufacturers for
seeking advance payment or a reservation fee for vaccines that are still under clinical trials.
He pledged to prioritise Russia or China, countries that he frequently praises during his
trademark verbal tirades at the West.
His government has talked to a number of potential vaccine suppliers, including those of
Russia and China plus U.S. drugmaker Pfizer Inc and Moderna Inc. It plans to meet
Australian biotech giant CSL Ltd.
A Philippine procurement law forbids payment of goods well ahead of delivery and before a
product's specifications are finalised, putting the country at a disadvantage amid expected
high global vaccine demand. The Philippines has recorded nearly 270,000 coronavirus
infections and over 4,600 deaths.
In contrast, countries like the United States and the United Kingdom have committed to buy
hundreds of millions of doses even as vaccines are still under late-stage trials.
The Philippines has joined a World Health Organization-led vaccine trials and allocation
plan and is promoting itself as a site for pharma firms' phase 3 trials, Vergeire said.
"We are doing all efforts to put us in a position to access these vaccines," Vergeire told a
regular news conference.